SCHEMBL14330548

SCHEMBL14330548

c1ccc(-c2cc(-c3ccccc3)cc(-c3ccc4ccc5c6c(ccc3c46)cc3c5c4cnccc4n3-c3ccccc3)c2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TNF P01375 1/20 0.36
▸ MAPK10 P53779 1/20 0.34
▸ CDC7 O00311 1/20 0.32
▸ CDK2 P24941 1/20 0.32
▸ DYRK1A Q13627 2/20 0.32
▸ REN P00797 1/20 0.32
▸ HASPIN Q8TF76 1/20 0.32
▸ CYP19A1 P11511 1/20 0.32
▸ ALOX5 P09917 1/20 0.31
▸ MEN1 O00255 2/20 0.31
▸ KMT2A Q03164 2/20 0.31
▸ HSP90AA1 P07900 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ TOP2A P11388 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ ATM Q13315 2/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ AOC3 Q16853 1/20 0.31
▸ GSK3B P49841 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14330589 0.91 DYRK1A (0.37) TNFMAPK10DYRK1ARENHASPIN
SCHEMBL14329611 0.90 MAPK10 (0.39) TNFMAPK10CDC7CDK2DYRK1A
SCHEMBL14330536 0.87 KDM4E (0.35) TNFCDC7CDK2DYRK1AHASPIN
SCHEMBL14330546 0.86 KDM4E (0.37) TNFMAPK10DYRK1ARENTOP2A
SCHEMBL14330557 0.85 TNF (0.33) TNFCDC7CDK2DYRK1AREN
SCHEMBL14330567 0.85 PTGS2 (0.39) MAPTALDH1A1KDM4E
SCHEMBL14331577 0.84 MGAT2 (0.38) TNFHASPINCYP19A1
SCHEMBL14330535 0.84 CYP11B1 (0.37) TNFDYRK1ARENALOX5TOP2A
SCHEMBL14330547 0.84 MAPK9 (0.32) MAPK10RENTOP2AATMKDM4E
SCHEMBL12731465 0.83 CYP11B1 (0.41) MEN1KMT2AMAPTALDH1A1ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8623521-B2 Heterocyclic compound and organic light-emitting diode and flat display device including the heterocyclic compound SAMSUNG DISPLAY CO., LTD. (KR) 2014-01-07 — — US disclosed
US-8623521-B2 Heterocyclic compound and organic light-emitting diode and flat display device including the heterocyclic compound SAMSUNG DISPLAY CO., LTD. (KR) 2014-01-07 — — US disclosed
US-20120326134-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DIODE AND FLAT DISPLAY DEVICE INCLUDING THE HETEROCYCLIC COMPOUND SAMSUNG DISPLAY CO., LTD. (KR) 2012-12-27 — — US disclosed
US-20120326134-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DIODE AND FLAT DISPLAY DEVICE INCLUDING THE HETEROCYCLIC COMPOUND SAMSUNG DISPLAY CO., LTD. (KR) 2012-12-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120326134-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DIODE AND FLAT DISPLAY DEVICE INCLUDING THE HETEROCYCLIC COMPOUND DDT, DRD1, HTR3D TNF 1386/4885MAPK10 3300/4885CDC7 1145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback